BFC Planning’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
BFC Planning's FLNA Position: Q3 2026 in Review
BFC Planning reduced its Filana Therapeutics (FLNA) stake by 76% in Q3 2026, selling an estimated $2.44K and leaving 822 shares worth $728. The position accounts for ﹤0.01% of the portfolio, ranked #3233.
BFC Planning first reported a position in FLNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $24.2K in Q3 2024. 60 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.
- BFC Planning held 822 shares of Filana Therapeutics worth $728 as of Q3 2026.
- BFC Planning sold 2,589 Filana Therapeutics shares in Q3 2026, an estimated $2.44K.
- Filana Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3233 holding.
- BFC Planning first reported a position in Filana Therapeutics in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Filana Therapeutics position peaked at $24.2K in Q3 2024.
- 60 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.